Physician profile
Anna Vaysman
NPI 1154737583
$3,180.25
in general payments reported to CMS, 2019-2025
11 companies · $60.21 in 2025
The $60.21 reported for 2025 was less than what a typical General Practice (Dentist) provider received nationally (typical 2025 total: $74.60).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $203 · 2020: $291 · 2021: $46.02 · 2022: $2,258 · 2023: $159 · 2024: $164 · 2025: $60.21.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $320 · Gift: $62.49.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $320.14 |
| Gift | $62.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dentsply Sirona INC | $1,418.66 | 2022-2024 | Astra Tech Implant System, Algin-X Ultra Alginate Alternative, Cerec |
| Ultradent Products INC | $831.46 | 2022-2024 | Opalescence |
| Sonendo INC | $292.21 | 2019-2020 | |
| Straumann USA LLC | $237.36 | 2019-2025 | |
| Nobel Biocare USA | $190.98 | 2020-2022 | |
| Align Technology, INC. | $100.30 | 2021-2025 | Invisalign |
| 3m Company | $40.61 | 2021-2023 | Filtek, 3m Espe Filtek Supreme Ultra Universal Restorative |
| Dmg America LLC | $33.97 | 2024 | |
| Philips North America LLC | $13.71 | 2022 | |
| Elevate Oral Care | $12.73 | 2023 | Fluorimax Mint, Advantage Arrest, Fluorimax 5000 |
| Voco America INC. | $8.26 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anna Vaysman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.